Trial Profile
Effects of Ranolazine and Exercise on Daily Physical Activity Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Dec 2017
Price :
$35
*
At a glance
- Drugs Ranolazine (Primary)
- Indications Angina pectoris
- Focus Pharmacodynamics
- Acronyms EREDA
- 20 Jun 2017 Status changed from active, no longer recruiting to completed.
- 29 Jun 2016 Status changed from recruiting to active, no longer recruiting.
- 23 May 2016 Planned primary completion date changed from 1 Mar 2016 to 1 Oct 2016.